SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001168220-18-000017
Filing Date
2018-05-15
Accepted
2018-05-15 16:23:22
Documents
74
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q MARCH 31, 2018 form10q_033118.htm 10-Q 638297
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex_31-1.htm EX-31.1 12080
3 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER ex_31-2.htm EX-31.2 12122
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex_32-1.htm EX-32.1 5807
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex_32-2.htm EX-32.2 5886
  Complete submission text file 0001168220-18-000017.txt   5181443

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ulu-20180331.xml EX-101.INS 939680
7 XBRL TAXONOMY EXTENSION SCHEMA ulu-20180331.xsd EX-101.SCH 50605
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ulu-20180331_cal.xml EX-101.CAL 57542
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ulu-20180331_def.xml EX-101.DEF 332213
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ulu-20180331_lab.xml EX-101.LAB 613253
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ulu-20180331_pre.xml EX-101.PRE 424482
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Filer) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33618 | Film No.: 18836875
SIC: 2834 Pharmaceutical Preparations